novo nordisk glp 1 pill says US approves first GLP-1 pill, Wegovy, for weight loss PRESS The first GLP-1 pill

Both agents target metabolic pathways relevant to diabetes and weight management, though through distinctly different molecular mechanisms

This prospective, single center, nonrandomized pilot study included 10 patients with AMI and LV disfunction after successful primary angioplasty compared with 11 control patients (21 patients in total)

Common sense about taste: from mammals to insects

Why GLPs Changed the Game Because for the first time, one class of therapy delivers: Sustainable weight reduction Durable glycemic control Meaningful cardio-metabolic risk reduction Impact on appetite, satiety, and behavior Strong real-world evidence, not just trials This is not incremental innovation